BAX three-lens brief
Evidence-based stock research on BAX. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Outperforming SPY by 16.5pp over 30 days. · Currently unprofitable on a trailing basis — no P/E multiple available.
- Outperforming SPY by 16.5pp over 30 days.
- Currently unprofitable on a trailing basis — no P/E multiple available.
- Earnings scheduled 2026-07-30.
BAX closed at $22.59 (+0.60%) as of 2026-07-10. Market cap: $11.67B. Price is above the 50-day MA and above the 200-day MA. Positives: outperforming SPY by 16.5pp over 30 days.. Concerns: currently unprofitable on a trailing basis — no P/E multiple available.. Last quarter: Revenue $2.70B, net income -$15.00M, free cash flow $900.88M. Watching for: 2026-07-30 earnings release (19 days out).
Why three lenses on BAX, not one.
A single reasoning model has blind spots it doesn’t know about. We examine BAXacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/BAX" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath BAX brief"></iframe>